Zech, H.B.; Schafhausen, P.; Ramke, L.; Velthaus, J.-L.; Kreutzfeldt, S.; Hübschmann, D.; Rothkamm, K.; Bokemeyer, C.; Hoffmann, A.S.; Fröhling, S.;
et al. Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and Functional Characterization. Biomedicines 2025, 13, 1266.
https://doi.org/10.3390/biomedicines13051266
AMA Style
Zech HB, Schafhausen P, Ramke L, Velthaus J-L, Kreutzfeldt S, Hübschmann D, Rothkamm K, Bokemeyer C, Hoffmann AS, Fröhling S,
et al. Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and Functional Characterization. Biomedicines. 2025; 13(5):1266.
https://doi.org/10.3390/biomedicines13051266
Chicago/Turabian Style
Zech, Henrike Barbara, Philippe Schafhausen, Leonie Ramke, Janna-Lisa Velthaus, Simon Kreutzfeldt, Daniel Hübschmann, Kai Rothkamm, Carsten Bokemeyer, Anna Sophie Hoffmann, Stefan Fröhling,
and et al. 2025. "Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and Functional Characterization" Biomedicines 13, no. 5: 1266.
https://doi.org/10.3390/biomedicines13051266
APA Style
Zech, H. B., Schafhausen, P., Ramke, L., Velthaus, J.-L., Kreutzfeldt, S., Hübschmann, D., Rothkamm, K., Bokemeyer, C., Hoffmann, A. S., Fröhling, S., Glimm, H., Betz, C. S., Kriegs, M., & Christopeit, M.
(2025). Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and Functional Characterization. Biomedicines, 13(5), 1266.
https://doi.org/10.3390/biomedicines13051266
